Loading…
Wild Horse and Burro Protection Act of 2023
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
71pct
16d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
Wild Horse and Burro Protection Act of 2023 This bill prohibits the Bureau of Land Management (BLM) from using or contracting for the use of helicopters or fixed-wing aircraft for gathering horses and burros under the Wild Free-roaming Horses and Burros Act. Further, BLM may not make contracts to use helicopters for transporting captured animals under such act.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2023 · third_quarter · Health Issues
Issues related to Prescription to over-the-counter switch; issues related to influenza vaccines; issues related to 340B program; issues related to Respiratory Syncytial Virus (RSV); issues related to routine immunization rates; general issues related to Vaccines; issues related to Clinical Trial Diversity; general issues related to drug pricing; issues related to Out of Pocket (OOP) Cap; general issues related to Insulin pricing; issues related to HR 5376 "Inflation Reduction Act"; issues related to Additional Condition for Prescription Use (ACNU); issues related to Copay Accumulators; issues related to HR 3656 "Vaccine Improvement Act"; issues related to HR 830 "HELP Copay Act"; issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA; issues related to HR 1503 "Prescription Information Modernization Act of 2023"; general issues related to FDA; issues related to FDA Drug development; issues related to Pharmacy Benefit Managers (PBM); issues related to insurance design; general issues related to Pandemic Preparedness; issues related to Vaccine Injury Compensation Program (VICP); issues related to Pandemic and All-Hazards Preparedness Act Reauthorization (PAHPA); issues related to S.1542 "DRUG Act", issues related to S.1375 "HELP Copays Act"; issues related to S.1339 "PBM Reform Act"; issues related to Pharmacy Benefits Managers Reform; issues related to HR 3285 "Fairness for Patient Medications Act"; issues related to transplants; issues related to delinking; issues related to HR 2880 "Protecting Patients Against PBM Abuses Act"; issues related to RSV immunizations; issues related to INSULIN ACT; issues related to MDRP Proposed Rule; issues related to HR 4421 "Preparing for all Hazards and Pathogens Reauthorization Act"; issues related to Share the Savings with Seniors Act in HR 5376; issues related to HR 3008 "Drug Shortage Prevention Act of 2023"; Issues related to HR 4988 "Modern Authentication of Pharmaceuticals Act"; and issues related to HR 4881 to amend title XVIII of the Social Security Act to limit cost sharing for drugs under Medicare Program.
Referred to the Subcommittee on Federal Lands.
Referred to the House Committee on Natural Resources.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Issues related to Prescription to over-the-counter switch; issues related to influenza vaccines; issues related to 340B program; issues related to Respiratory Syncytial Virus (RSV); issues related to routine immunization rates; general issues related to Vaccines; issues related to Clinical Trial Diversity; general issues related to drug pricing; issues related to Out of Pocket (OOP) Cap; general issues related to Insulin pricing; issues related to HR 5376 "Inflation Reduction Act"; issues related to Additional Condition for Prescription Use (ACNU); issues related to Copay Accumulators; issues related to HR 3656 "Vaccine Improvement Act"; issues related to HR 830 "HELP Copay Act"; issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA; issues related to HR 1503 "Prescription Information Modernization Act of 2023"; general issues related to FDA; issues related to FDA Drug development; issues related to Pharmacy Benefit Managers (PBM); issues related to insurance design; general issues related to Pandemic Preparedness; issues related to Vaccine Injury Compensation Program (VICP); issues related to Pandemic and All-Hazards Preparedness Act Reauthorization (PAHPA); issues related to S.1542 "DRUG Act", issues related to S.1375 "HELP Copays Act"; issues related to S.1339 "PBM Reform Act"; issues related to Pharmacy Benefits Managers Reform; issues related to HR 3285 "Fairness for Patient Medications Act"; issues related to supply chain; issues related to transplants; issues related to delinking; and issues related to HR 2880 "Protecting Patients Against PBM Abuses Act".
Client expense: $1,120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Issues related to Prescription to over-the-counter switch; issues related to influenza vaccines; issues related to 340B program; issues related to Respiratory Syncytial Virus (RSV); issues related to routine immunization rates; general issues related to Vaccines; issues related to Reconciliation; issues related to Cosmetic Reform; issues related to Clinical Trial Diversity; general issues related to drug pricing; issues related to Out of Pocket (OOP) Cap; general issues related to Insulin pricing; issues related to HR 5376 "Inflation Reduction Act"; issues related to Additional Condition for Prescription Use (ACNU); issues related to Copay Accumulators; issues related to HR 3656 "Vaccine Improvement Act"; issues related to HR 830 "HELP Copay Act"; issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA; issues related to HR 1503 "Prescription Information Modernization Act of 2023"; general issues related to FDA; issues related to FDA Drug development; issues related to Pharmacy Benefit Managers (PBM); issues related to insurance; and general issues related to Pandemic Preparedness.
Client expense: $1,860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| PA |
| Danny K. Davis | Democratic | IL |
| David Schweikert | Republican | AZ |
| Deborah K. Ross | Democratic | NC |
| Diana DeGette | Democratic | CO |
| Donald G. Davis | Democratic | NC |
| Eleanor Holmes Norton | Democratic | DC |
| Gerald E. Connolly | Democratic | VA |
| James A. Himes | Democratic | CT |
| Jill N. Tokuda | Democratic | HI |
| Joe Neguse | Democratic | CO |
| Josh Gottheimer | Democratic | NJ |
| Maria Elvira Salazar | Republican | FL |
| Mark Pocan | Democratic | WI |
| Nick LaLota | Republican | NY |
| Rashida Tlaib | Democratic | MI |
| Raul Ruiz | Democratic | CA |
| Sean Casten | Democratic | IL |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Ted Lieu | Democratic | CA |
| Thomas R. Suozzi | Democratic | NY |
| William R. Keating | Democratic | MA |
| Zoe Lofgren | Democratic | CA |